tradingkey.logo
搜索

Simulations Plus Inc

SLP
添加自选
18.390USD
+0.040+0.22%
收盘 07/02, 13:00美东报价延迟15分钟
370.50M总市值
亏损市盈率 TTM

关于 Simulations Plus Inc 公司

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Simulations Plus Inc简介

公司代码SLP
公司名称Simulations Plus Inc
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)
员工数量212
证券类型Ordinary Share
年结日Jun 18
公司地址800 Park Offices Drive, Suite 401
城市RESEARCH TRIANGLE PARK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编27709
电话16617237723
网址https://www.simulations-plus.com/
公司代码SLP
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)

Simulations Plus Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--
Ms. Lisa Fortuna
Ms. Lisa Fortuna
Investor Relations
Investor Relations
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--

常见问题

Simulations Plus Inc的前五大股东是谁?

Simulations Plus Inc 的前五大股东如下:Dr. Hon. Walter S. Woltosz

有多少机构持有Simulations Plus Inc(SLP)的股份?

截至2026Q1,共有432家机构持有Simulations Plus Inc的股份,合计持有的股份价值约为17.68M,占公司总股份的87.48%。与2025Q4相比,机构持股有所增加,增幅为-4627215.00。

哪个业务部门对Simulations Plus Inc的收入贡献最大?

在2026Q1,Consulting services业务部门对Simulations Plus Inc的收入贡献最大,创收9.54M,占总收入的51.78%。